Juntendo University, Tokyo, established in 1838.

1. Kazuya Takamochi M.D., Ph.D. (Associate Professor, JU): Management of Stage III Lung Cancer / Challenging Cases in Lung Cancer. Asian Cancer Conference 2018, Nov. 9-10, 2018 at Chulalongkorn University, Bangkok, Thailand
2. Junya Fujimoto M.D., Ph.D. (Assistant Professor, MDA): Next generation sequence analysis and immunotherapeutics-related analysis at the Department of Translational Molecular Pathology of MDA. Aug. 22, 2017 at JU
3. Marito Araki Ph.D. Genomic and Functional Analysis for Understanding Hematological Malignancies. Oncology Forum 2017, July 30, 2017 at JU
4. Marito Araki Ph.D. (Associate Professor, JU): The Mechanism of Development of Myeloproliferative Neoplasms by Mutant Calreticuli. May. 10, 2017, at MDA
5. Junya Fujimoto M.D., Ph.D. (Assistant Professor, MDA): Multidisciplinary Research Projects at Department of Translational Molecular Pathology. Aug. 11, 2015, at JU
6. Hirohito Yamaguchi, Ph.D. (Associate Professor, MDA): Why I am in MDA ~ career in USA~. Oct. 14, 2015, at JU
7. Hirohito Yamaguchi, Ph.D. (Associate Professor, MDA): The regulation and role of histonmethyltransferase EZH2 in Cancer. June 20, 2014, at JU
8. Yoshihide Hayashizaki, M.D., Ph.D. (Director, RIKEN): New gene expression regulation world based on transcriptome network, July 15, 2014, at MDA
9. Yoshihide Hayashizaki, M.D., Ph.D. (Director, RIKEN): Introduction of RIKEN technologies for new, advanced medical care. July 16, 2014, at MDA

GAP 2019 Conference　(Houston, Texas)

1. Tian Y, Denda-Nagai K, Ishii-Schrade K, Matsuzaki K, Hafley M, Bresalier R, Irimura T. Mucin 21 confers resistance to apoptosis in an O-glycosylation dependent manner. GAP 2019 Conference, Houston, 2019.
2. Miyatsu T, Okamoto A. Factors enabling breast cancer patients to continue working during post-operative radiotherapy. GAP 2019 Conference, Houston, 2019.
3. Kurihara A, Tabe Y Conflicted feeling of the cancer patient with mother-daughter relationship problem. GAP 2019 Conference, Houston, 2019.
4. Kimura K, Tabe Y, Ai T, Takehara, Uchihashi K, Ohsaka A. A novel automated image analysis using deep convolutional neural networks in the diagnosis of myelodysplastic syndromes. GAP 2019 Conference, Houston, 2019.
5. Yamatani K, Tabe Y, Saito K, Yang H, Zhang W, Kinjo S, Ikeo K, Kaczkowski B, Miida T, Konopleva M, Hayashizaki Y, Andreeff M. CAGE transcriptome identified Bcl-2 as a novel molecular target of FLT3-ITD AML with acquired TKD mutation. GAP 2019 Conference, Houston, 2019.
6. Tabe Y, Yang H, Saito K, Jacamo R, Ma H, Ruvolo V, Imoto J, Ikeo K, Yamatani K, Miida T, Hayashizaki Y, Andreeff M, Marszalek J,  Konopleva M, Tunneling NanoTubes formation as a mechanism of microenvironment-induced resistance to OxPhos inhibition in AML. GAP 2019 Conference, Houston, 2019.
7. Tabe Y. Mitochondrial transfer confers microenvironment-mediated resistance to oxphos inhibition in AML. GAP 2019 Conference, Houston, 2019.
8. Shimizu Y. Kondo A, Adachi S, Arai H. The Role of KIAA1549-BRAF Fusion Gene in Pediatric Brain Tumor. GAP 2019 Conference, Houston, 2019.
9. Fujita N, Kondo A, Arai H. Molecular subgrouping of posterior fossa ependymoma by CRIP1 gene methylation status. GAP 2019 Conference, Houston, 2019.

GAP 2018 Conference　(Stockholm, Sweden)

1. Nagaya N. The expression of PSMA in CTCs as a predictive marker for poor treatment response in CRPC. GAP 2018 Conference, Stockholm, 2018.
2. Tabe Y. Novel Oxidative phosphorylation inhibitor IACS-010759 inhibits p38MAPK-NFkB signaling pathways. GAP 2018 Conference, Stockholm, 2018.
3. Uehara Y. Enterobacter species bacteremia in patients with malignancy: a pilot analysis. GAP 2018 Conference, Stockholm, 2018.
4. Kurihara A. Grief caused by the death of female cancer patients：daughters perspectives. GAP 2018 Conference, Stockholm, 2018.
5. Fujimura Y. Intervention through multi-professional collaboration for older people with malnutrition by cancer. GAP 2018 Conference, Stockholm, 2018.
6. Ohsaka A. Eprobe mediated RT-qPCR for the detection of leukemia-associated translocations. GAP 2018 Conference, Stockholm, 2018.
7. Kimura K. Development and validation of a Deep Learning Algorithm for detection of abnormal morphology of WBC. GAP 2018 Conference, Stockholm, 2018.

GAP 2017 Conference　(Houston, Texas)

1. Araki M. Mutant Calreticulin activates the thrombopoietin receptor in myeloproliferative neoplasms. GAP 2017 Conference, Houston, 2017.
2. Shimizu Y. Characterization of Patient Derived Bone-Marrow Human Mesenchymal Stem Cells as Virus Carriers for the Treatment of Glioblastoma. GAP 2017 Conference, Houston, 2017.
3. Uehara Y. Molecular types of newly-isolated methicillin-resistant Staphylococcus aureus in a month, 2015, in a Japanese university hospital. GAP 2017 Conference, Houston, 2017.
4. Tabe Y. Bone marrow adipocytes facilitate fatty acid oxidation activating AMPK and a transcriptional network supporting survival of acute monocytic leukemia cells. GAP 2017 Conference, Houston, 2017.
5. Kanayama M. Differentiation in LNCaP Prostate Cancer Cell with Concurrent Up-regulation of Interferon Regulatory Factor 1. GAP 2017 Conference, Houston, USA, 2017.

GAP 2016 Conference (São Paulo, Brazil)

1. Kondo A. The impact of molecular analysis for pediatric brain tumors in clinical field. GAP 2016 Conference, São Paulo, Brazil, 2016.
2. Kondo A. Overexpression of TEAD4 in AT/RT; New insight to the pathophysiology of an aggressive brain tumor. GAP 2016 Conference, São Paulo, Brazil, 2016.
3. Imai M. Identification of candidate genes for granulosa cell tumor progression. GAP 2016 Conference, São Paulo, Brazil, 2016.

GAP 2015 Conference　(Houston, US)

1. Tabe Y, Mogushi K, Kazuno S, Fujimura T, Samudio I, Yamanaka Y, Miida T, Konopleva M, Hayashizaki Y, Andreeff M. Bone marrow adipocytes induced activation of fatty acid oxidation contributes to survival of acute monocytic leukemia cells. GAP 2015 Conference, Houston, 2015.

GAP 2014 Conference (Seoul, Korea)

1. Tabe Y, Kojima K, Jin L, Iwanami H, Matsushita H, Kazuno S, Kauffman M, Shacham S, Fujimura T, Ueno T, Miida T, Andreeff M. Molecular mechanisms of inhibition of ribosomal biogenesis and translational flux by the Selective Inhibitor of Nuclear Export (SINE) XPO1/CRM1 antagonist KPT-185 in mantle cell lymphoma. GAP 2014 Conference, Seoul, 2014.